Related Experiment Videos
STF-IL-4: a novel IL-4-induced signal transducing factor
C Schindler1, H Kashleva, A Pernis
1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
The EMBO Journal
|March 15, 1994
Summary
Interleukin-4 (IL-4) activates a novel DNA-binding factor, STF-IL-4, which regulates gene expression. This rapid, tyrosine kinase-dependent process involves cytoplasmic and nuclear translocation, similar to interferon signaling.
Area of Science:
- Immunology
- Molecular Biology
- Gene Regulation
Background:
- The precise mechanisms by which interleukin-4 (IL-4) controls gene expression remain largely unelucidated.
- Understanding IL-4's regulatory pathways is crucial for comprehending immune responses and developing targeted therapies.
Purpose of the Study:
- To identify and characterize the DNA-binding factor induced by IL-4.
- To elucidate the activation and localization dynamics of this IL-4-induced factor.
Main Methods:
- Utilized DNA-binding assays to detect and characterize the IL-4-induced factor (STF-IL-4).
- Investigated the kinetics and cellular localization of STF-IL-4 activation.
- Assessed the role of protein synthesis and tyrosine kinases in STF-IL-4 activation.
Main Results:
- Identified a novel IL-4-induced DNA-binding factor, STF-IL-4, with high affinity for IFN-gamma activation sites (GAS).
- Demonstrated that STF-IL-4 binds to the IL-4 responsive promoter of the Ig heavy chain germline epsilon transcript.
- Observed rapid, protein synthesis-independent activation of STF-IL-4, with sequential cytoplasmic and nuclear appearance.
- Found STF-IL-4 activation to be sensitive to tyrosine kinase inhibitors, with the active factor being tyrosine phosphorylated.
Conclusions:
- STF-IL-4 represents a new cytokine-induced transcriptional regulator, likely playing a key role in IL-4-mediated gene expression.
- The activation pathway of STF-IL-4 shares similarities with interferon-induced transcription factors, suggesting a conserved signaling mechanism.
- Further research into STF-IL-4 could reveal new therapeutic targets for immune-related diseases.